Co-reporter:Jacqueline Naylor;Aisling Minard;Hannah J Gaunt;Mohamed S Amer;Lesley A Wilson;Marco Migliore;Sin Y Cheung;Hussein N Rubaiy;Nicola M Blythe;Katie E Musialowski;Melanie J Ludlow;William D Evans;Ben L Green;Hongjun Yang;Yun You;Jing Li;Colin W G Fishwick;Katsuhiko Muraki;David J Beech;Robin S Bon
British Journal of Pharmacology 2016 Volume 173( Issue 3) pp:562-574
Publication Date(Web):
DOI:10.1111/bph.13387
Background and Purpose
The TRPC5 proteins assemble to create calcium-permeable, non-selective, cationic channels. We sought novel modulators of these channels through studies of natural products.
Experimental Approach
Intracellular calcium measurements and patch clamp recordings were made from cell lines. Compounds were generated by synthetic chemistry.
Key Results
Through a screen of natural products used in traditional Chinese medicines, the flavonol galangin was identified as an inhibitor of lanthanide-evoked calcium entry in TRPC5 overexpressing HEK 293 cells (IC50 0.45 μM). Galangin also inhibited lanthanide-evoked TRPC5-mediated current in whole-cell and outside-out patch recordings. In differentiated 3T3-L1 cells, it inhibited constitutive and lanthanide-evoked calcium entry through endogenous TRPC5-containing channels. The related natural flavonols, kaempferol and quercetin were less potent inhibitors of TRPC5. Myricetin and luteolin lacked effect, and apigenin was a stimulator. Based on structure–activity relationship studies with natural and synthetic flavonols, we designed 3,5,7-trihydroxy-2-(2-bromophenyl)-4H-chromen-4-one (AM12), which inhibited lanthanide-evoked TRPC5 activity with an IC50 of 0.28 μM. AM12 also inhibited TRPC5 activity evoked by the agonist (−)-Englerin A and was effective in excised outside-out membrane patches, suggesting a relatively direct effect. It inhibited TRPC4 channels similarly, but its inhibitory effect on TRPC1–TRPC5 heteromeric channels was weaker.
Conclusions and Implications
The data suggest that galangin (a natural product from the ginger family) is a TRPC5 inhibitor and that other natural and synthetic flavonoids contain antagonist or agonist capabilities at TRPC5 and closely related channels depending on the substitution patterns of both the chromone core and the phenyl ring.
Co-reporter:Martin J. Fisher, Daniel J. Williamson, George M. Burslem, Jeffrey P. Plante, Iain W. Manfield, Christian Tiede, James R. Ault, Peter G. Stockley, Sven Plein, Azhar Maqbool, Darren C. Tomlinson, Richard Foster, Stuart L. Warriner and Robin S. Bon
RSC Advances 2015 vol. 5(Issue 116) pp:96194-96200
Publication Date(Web):02 Nov 2015
DOI:10.1039/C5RA20359G
The development of novel protein-targeted MRI contrast agents crucially depends on the ability to derivatise suitable targeting moieties with a high payload of relaxation enhancer (e.g., gadolinium(III) complexes such as Gd-DOTA), without losing affinity for the target proteins. Here, we report robust synthetic procedures for the preparation of trivalent Gd-DOTA reagents with various chemical handles for site-specific modification of biomolecules. The reagents were shown to successfully label proteins through isothiocyanate ligation or through site-specific thiol–maleimide ligation and strain-promoted azide–alkyne cycloaddition.
Co-reporter:James Murray, Dominika Nowak, Laurynas Pukenas, Rizuan Azhar, Mathieu Guillorit, Christoph Wälti, Kevin Critchley, Steven Johnson and Robin S. Bon
Journal of Materials Chemistry A 2014 vol. 2(Issue 24) pp:3741-3744
Publication Date(Web):23 Apr 2014
DOI:10.1039/C4TB00573B
We present an efficient solid phase synthesis methodology that provides easy access to a range of functionalised long-chain alkanethiol–oligoethyleneglycols that form well-defined self-assembled monolayers on gold and are compatible with pre- or post-assembly conjugation of (bio)molecules. We demonstrate the versatility of our synthetic route by synthesising LCAT–OEGs with a range of functional moieties, including peptides, electro-active redox groups, chemical handles for post-assembly conjugation of (bio)molecules, and demonstrate the application of our LCAT–OEG monolayers in immunosensing, where they show good biocompatibility with minimal biofouling.
Co-reporter:James Murray, Dominika Nowak, Laurynas Pukenas, Rizuan Azhar, Mathieu Guillorit, Christoph Wälti, Kevin Critchley, Steven Johnson and Robin S. Bon
Journal of Materials Chemistry A 2014 - vol. 2(Issue 24) pp:NaN3744-3744
Publication Date(Web):2014/04/23
DOI:10.1039/C4TB00573B
We present an efficient solid phase synthesis methodology that provides easy access to a range of functionalised long-chain alkanethiol–oligoethyleneglycols that form well-defined self-assembled monolayers on gold and are compatible with pre- or post-assembly conjugation of (bio)molecules. We demonstrate the versatility of our synthetic route by synthesising LCAT–OEGs with a range of functional moieties, including peptides, electro-active redox groups, chemical handles for post-assembly conjugation of (bio)molecules, and demonstrate the application of our LCAT–OEG monolayers in immunosensing, where they show good biocompatibility with minimal biofouling.